The move comes after Asahi Kasei signed a definitive agreement to acquire all issued shares of Aicuris for approximately 780m ($920.7m) earlier this year.
pharminent
April 21, 2026 (Last updated: April 21, 2026)
Pharmaceutical Business Review
The move comes after Asahi Kasei signed a definitive agreement to acquire all issued shares of Aicuris for approximately 780m ($920.7m) earlier this year.
